PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer. - Guerin, Mathilde; Rezai, Keyvan; Isambert, Nicolas; Campone, Mario; Autret, Aurélie; Pakradouni, Jihane; Provansal, Magali; Camerlo, Jacques; Sabatier, Renaud; Bertucci, François; Charafe-Jauffret, Emmanuelle; Hervieu, Alice; et al. (European Journal of Cancer, 2017)